insights_auto
Kwa nini TWST imeongezeka kwa 3.08%?
Fahamu zaidichevron_right
TWST:NASDAQ
Twist Bioscience Corp
US$ 144.07
arrow_upward
+3.08%(+4.30) Siku 1
20 Okt, 15:54:05 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya TWST...
Fungua
US$ 139.77
Juu
US$ 148.83
Chini
US$ 134.94
Mtaji wa soko
9.55B
Wastani wa kiasi cha mauzo
2.84M
Kiasi cha mauzo ya hisa
1.53M
Juu kwa wiki 52
US$ 219.71
Chini kwa wiki 52
US$ 23.30
EPS
-US$ 2.22
Beta
2.19
Hisa za wawekezaji
65.83M
Idadi ya wafanyakazi
979
Fungua
US$ 139.77
Juu
US$ 148.83
Chini
US$ 134.94
Mtaji wa soko
9.55B
Wastani wa kiasi cha mauzo
2.84M
Kiasi cha mauzo ya hisa
1.53M
Juu kwa wiki 52
US$ 219.71
Chini kwa wiki 52
US$ 23.30
EPS
-US$ 2.22
Beta
2.19
Hisa za wawekezaji
65.83M
Idadi ya wafanyakazi
979
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 7 zilizopita
TD Cowen lifts target to USD 190 for Twist Bioscience stock
Simply Wall Street
·
saa 11 zilizopita
Is Twist Bioscience (TWST) Too Rich Or Still Reasonable On Sales?
Wasifu
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Kuhusu Twist Bioscience Corp
Afisa Mkuu Mtendaji (CEO)Emily LeProust
Wafanyakazi979
Lilianzishwa2013
Makao makuu-
Sekta-
Tovutitwistbioscience.com